^
Association details:
Biomarker:No biomarker
Cancer:Gastrointestinal Stromal Tumor
Drug:Tasigna (nilotinib) (Bcr-abl tyrosine kinase inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
Gastrointestinal Stromal Tumors: Systemic Therapy agents and regimens for unresectable GIST with significant morbidity...Useful in certain circumstances…Nilotinib